Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00473707 · ClinicalTrials.gov registry record · NA
Active Versus Expectant Management of the Third Stage of Labor
A NA study of Postpartum Hemorrhage, sponsored by Christiana Care Health Services.
- Completed
- Registry status
- NA
- Development phase
- 218
- Enrollment target
- 1
- Study location
NCT00473707: Completed NA study of Postpartum Hemorrhage, sponsored by Christiana Care Health Services.
NCT00473707 is a NA study of Postpartum Hemorrhage that has completed, run by Christiana Care Health Services. The registered enrollment target is 218 participants, below the 769-participant average among 19 other Postpartum Hemorrhage trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00473707, a NA study of Postpartum Hemorrhage, has completed, sponsored by Christiana Care Health Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 218 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if giving oxytocin immediately after delivery causes less bleeding, transfusion needs and hastens delivery of placenta.
Conditions Studied
Interventions
- DRUG Oxytocin
- PROCEDURE Active management of the third stage of labor
- PROCEDURE Expectant management of the third stage of labor
- DRUG Oxytocin and gentle cord traction with fundal massage
Study Locations (1)
Delaware
- Christiana Care Health System - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2002-08 |
| Est. Completion | 2006-07 |
| Phase | NA |
What the finished NCT00473707 record still lists
NCT00473707 is an interventional study that assigns participants to a tested intervention. The registered 218 participants enrollment target is mid-sized for trials with a published cap, below the 769-participant average among 19 other Postpartum Hemorrhage trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Postpartum Hemorrhage appearing as the primary indexed condition, and to 4 interventions - of which Oxytocin is the first listed.
NCT00473707 reports a single indexed study location in Delaware.
Frequently Asked Questions
What is clinical trial NCT00473707 about?
NCT00473707 is a clinical study titled "Active Versus Expectant Management of the Third Stage of Labor". The purpose of this study is to determine if giving oxytocin immediately after delivery causes less bleeding, transfusion needs and hastens delivery of placenta.
What is the current status of trial NCT00473707?
This trial is currently completed. It is a NA study. The enrollment target is 218 participants. The study started on 2002-08. Estimated completion is 2006-07.
What conditions does trial NCT00473707 study?
This clinical trial studies the following conditions: Postpartum Hemorrhage.
What interventions are being tested in trial NCT00473707?
The interventions under investigation include: Oxytocin (DRUG), Active management of the third stage of labor (PROCEDURE), Expectant management of the third stage of labor (PROCEDURE), Oxytocin and gentle cord traction with fundal massage (DRUG).
Who is sponsoring clinical trial NCT00473707?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00473707 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00473707's enrollment target sits among peer trials
218 5th of 19 higher than 15 of 19 other Postpartum Hemorrhage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postpartum Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage
RECRUITING · NA
-
A Pragmatic Randomized Controlled Trial to Predict Postpartum Hemorrhage
RECRUITING · NA
-
Postpartum Oxytocin Administration in the Era of Delayed Cord Clamping
COMPLETED · NA
-
Implementation of the NPMS Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method
COMPLETED · NA
-
Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
COMPLETED · NA
-
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04693858 · 218 participants · NA
Efficacy Trial of the CALM Intervention
- NCT05909202 · 218 participants · NA
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
- NCT06000761 · 218 participants · NA
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
- NCT06249126 · 218 participants · NA
Primary Subtalar Arthrodesis for Calcaneal Fractures
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia